Join us November 7-8, 2025!
Join us for the 4th Annual Charleston Head & Neck Oncology Symposium at the Sweetgrass Inn at Wild Dunes Resort. The 4th Annual Charleston Head & Neck Oncology Symposium is a two-day event during which international specialists will present the latest research into the prevention, diagnosis, treatment and recovery from head and neck cancer. Click below to register for the symposium now!
Meet our Keynote Speakers
Michael G. Moore, MD, FACS
Indiana University School of Medicine
Arilla Spence DeVault Professor of Otolaryngology-Head and Neck Surgery
Medical Director of IUH Joe and Shelly Schwarz Cancer Center
Michael Moore, MD, is the Arilla Spence DeVault Professor in the Indiana University School of Medicine Department of Otolaryngology — Head and Neck Surgery and serves as the Chief of the Division of Head and Neck Surgery.
Dr. Moore specializes in cancer removal and reconstructive surgery in the head and neck. He manages benign and malignant tumors located in the mouth, throat, skin, salivary glands, thyroid (parathyroid), nose, sinuses and anterior skull base. He has a particular interest in the management of advanced and recurrent head and neck malignancies, including skull base tumors and those in need of reconstruction using microvascular free tissue transfer. His expertise also includes endoscopic and minimally invasive procedures through transoral robotic surgery and/or laser surgery.
Dr. Moore’s passion for head and neck cancer management comes from the challenge of treating cancer in this anatomically sensitive location. Head and neck tumors and their treatments frequently impact patients in areas that are very personal to them, such as their appearance as well as their ability to eat, drink and breathe. As a result, Dr. Moore is devoted to optimize the chance for cure while minimizing the functional and cosmetic side effects that could come with treatment.
Nationally recognized in the profession, Dr. Moore serves as the Chair of the Cancer Prevention Service of the American Head and Neck Society (AHNS) and is one of three head and neck surgeons on the American Cancer Society HPV Vaccination Roundtable. He is President of the Board of the Head and Neck Cancer Alliance, a not-for-profit organization devoted to the early detection and prevention of head and neck cancer and supporting those affected by the disease.
Ongoing research includes early detection and prevention of disease with an emphasis on strategies for increasing HPV vaccination rates as well as the development of novel techniques for head and neck cancer screening. In addition to his academic pursuits, Dr. Moore teams with physicians around the world each year to provide surgical services and train local surgeons in eastern sub-Saharan Africa.
Dr. Moore earned his medical degree from UCLA School of Medicine and got his residency training in otolaryngology—head and neck surgery at Harvard Medical School before completing a fellowship in head and neck oncology and reconstructive surgery from the University of Washington. Learn more about Dr. Moore.
Cesar A. Perez, MD
Director of Drug Development, Lake Nona DDU
Sarah Cannon Research Institute at Florida Cancer Specialists
Executive Chair, SCRI Head and Neck Research Committee
Associate Professor of Medicine
University of Central Florida Cancer Center
Dr. Perez is a board-certified medical oncologist and hematologist with Florida Cancer Specialists & Research Institute in Orlando, Florida.
Dr. Perez is director of the Drug Development Unit at the Sarah Cannon Research Institute at Florida Cancer Specialists & Research Institute (FCS) in Lake Nona, Florida, one of three within the statewide practice that focus exclusively on advancing cancer treatment through early-phase clinical trials research.
A globally-recognized cancer expert who has dedicated his career to transformational oncology research, Dr. Perez leads the development of novel therapies for all solid tumors, with a specialized focus on head and neck cancer. He is executive chair of the Head and Neck Cancer Group for the Sarah Cannon Network and an affiliate associate professor at the University of Central Florida.
Dr. Perez has served as principal investigator for numerous clinical trials, including first in-human trials. He has authored and co-authored several abstracts published in prestigious clinical journals and presented at national and global symposiums.
Dr. Perez has held prestigious roles and committee appointments. He serves as an ASCO® (American Society of Clinical Oncology) Ambassador, as chair of the Head and Neck Educational Committee for the ASCO® annual meeting, and as a member of its scientific and educational committees of oncology physicians and professionals from around the globe working to conquer cancer through research, education, policy and promotion of high quality and equitable patient care.
Prior to joining FCS in 2021, Dr. Perez served as associate professor of medicine at the University of Miami, where he co-led Phase 1 oncology clinical research as well as the Head and Neck Group, and as assistant professor of medicine at the University of Louisville, where he received the Best Faculty Teacher Award in 2015 and 2017.
Dr. Perez earned his medical degree from the University of Panama School of Medicine. He completed his internal medicine residency at the Cleveland Clinic in Florida and pursued his oncology-hematology fellowship at the University of Miami, where he served as chief fellow and was honored with the Peter A. Cassileth, MD Award as an outstanding fellow.